Komori
Tohoku Chemical (7446) · TargetAchieved

FY2022 consolidated revenue target of ¥33.8 billion, operating profit of ¥578 million, ordinary profit of ¥611 million and profit attributable to owners of the parent of ¥433 million

First written in FY2021. 3 of 5 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2022.

5entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021AdvancedFY2022-Q1 – FY20222021: 12022: 42022
Same theme, other companies
Consolidated performance targets for the fiscal year ending September 2022A theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2022AchievedAnnual report

    「As a result, compared with the previous consolidated fiscal year, net sales increased by ¥1,112 million, or 3.1%, to ¥37,333 million; operating income increased by ¥230 million, or 32.4%, to ¥944 million; ordinary income increased by ¥244 million, or 32.2%, to ¥1,003 million; and net income attributable to owners of the parent increased by ¥140 million, or 27.3%, to ¥657 million.」

    Against the FY2022 targets of revenue of ¥33.8 billion, operating profit of ¥578 million, ordinary profit of ¥611 million and profit attributable to owners of the parent of ¥433 million, actual results exceeded all four targets.
  2. FY2022-Q3AdvancedAnnual report

    「As a result, compared with the same quarter of the previous year, net sales increased by ¥697 million, or 2.6%, to ¥27,901 million; operating income increased by ¥191 million, or 33.5%, to ¥763 million; ordinary income increased by ¥205 million, or 33.9%, to ¥814 million; and net income attributable to owners of the parent increased by ¥111 million, or 25.9%, to ¥538 million.」

    For the nine months ended June 2022, revenue of ¥27.901 billion, operating profit of ¥763 million, ordinary profit of ¥814 million and profit attributable to owners of the parent for the quarter of ¥538 million were recorded against the FY2022 targets. Operating profit, ordinary profit and net profit exceeded their full-year targets, while revenue was also progressing toward the full-year target of ¥33.8 billion.
  3. FY2022-Q2AdvancedAnnual report

    「As a result, compared with the same quarter of the previous year, net sales increased by ¥904 million, or 4.9%, to ¥19,194 million; operating income increased by ¥101 million, or 22.6%, to ¥551 million; ordinary income increased by ¥105 million, or 22.6%, to ¥572 million; and net income attributable to owners of the parent increased by ¥48 million, or 15.0%, to ¥372 million.」

    For the six months ended March 2022, revenue of ¥19.194 billion, operating profit of ¥551 million, ordinary profit of ¥572 million and profit attributable to owners of the parent for the quarter of ¥372 million were recorded against the FY2022 targets. All items increased year on year.
  4. FY2022-Q1AdvancedAnnual report

    「As a result, compared with the same quarter of the previous year, net sales increased by ¥467 million, or 5.5%, to ¥9,042 million; operating income increased by ¥78 million, or 58.3%, to ¥214 million; ordinary income increased by ¥81 million, or 55.4%, to ¥228 million; and net income attributable to owners of the parent increased by ¥51 million, or 52.7%, to ¥148 million.」

    For the first quarter of FY2022, revenue of ¥9.042 billion, operating profit of ¥214 million, ordinary profit of ¥228 million and profit attributable to owners of the parent for the quarter of ¥148 million were recorded against the full-year targets.
  5. FY2021First statedAnnual report

    「The Group will work toward achieving targets of revenue of ¥33.8 billion (down 6.7% from the previous consolidated fiscal year), operating profit of ¥578 million (down 18.9%), ordinary profit of ¥611 million (down 19.5%) and profit attributable to owners of the parent of ¥433 million (down 16.1%).」

    For FY2022, specific targets were set for four items: revenue, operating profit, ordinary profit and profit attributable to owners of the parent.
Moved together

"Improving Performance Through Revenue and Profit Growth" moved the same way as this thread, in the same document, in 4 of its 5 moves.

44443★12345
  1. ★This thread
  2. 1Improving Performance Through Revenue and Profit Growth4×
  3. 2Recovery in demand related to electronic components and generic pharmaceuticals4×
  4. 3Expanding demand, new adoption and margin improvement for clinical laboratory reagents4×
  5. 4Decline in cash and cash equivalents and cash outflows from operating activities4×
  6. 5Increase in Total Assets, Liabilities and Net Assets3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Tohoku Chemical's next results are scheduled for 2026-11-13. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.